Brother of CDO (BOC) is a cell surface receptor that derives its name from the structurally related protein, cell adhesion molecule-related/down-regulated by oncogenes (CDO, sometimes CDON). High levels of BOC mRNA and protein expression have been described in embryonic tissues with active cell proliferation and ongoing cellular differentiation 1, 2 . A microarray-based screen of RNA isolated from 11 different adult equine tissues unexpectedly identified BOC as having an expression pattern restricted to articular cartilage. The objective of this study was to further investigate BOC expression in adult articular cartilage relative to other tissues. Both RT-qPCR and mRNA sequencing confirmed the microarray data. Steady state BOC mRNA levels in articular cartilage were substantially higher than in the other adult tissues tested, neonatal tendon, placenta, and whole embryo. The expression of BOC displayed a pattern of tissue specificity comparable to well established cartilage matrix protein biomarkers. BOC mRNA levels in articular cartilage increased with age, but were rapidly down-regulated when chondrocytes were enzymatically isolated from the cartilage matrix and expanded in monolayer culture. Relative expression patterns of CDO were broadly similar, but displayed lower fold change differences. A functional role in articular cartilage that involves Hedgehog signaling is suggested by the known binding affinity of BOC for all three Hedgehog ligands. These data also extend BOC and CDO biology to a post-mitotic and highly differentiated cell type within a mature tissue.
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Methods, results, and discussion
Equine tissue samples were collected under approved Institutional Animal Care and Use Committee protocols. Total RNA was isolated using variations of acid guanidinium thiocyanate/phenol/ chloroform extraction with alcohol and salt precipitations, processed with a final RNeasy silica gel column purification (Qiagen Inc., Valencia, CA, #74104), ethanol precipitated, and solubilized in nuclease-free water (Ambion, #AM9937). Quantitative and qualitative parameters of the RNA preparations were assessed using a NanoDrop ND-1000 spectrophotometer and a Bioanalyzer 2100 (Agilent Technologies, Eukaryotic Total RNA Nano Series II). Samples had 260/280 ratios of 1.7e2.0, 260/230 ratios of 1.8e2.1, and an Agilent RNA integrity number (RIN) of !8.0.
Microarray-based transcriptional profiling was used to compare adult full thickness articular cartilage to 10 other equine tissues using a 9413-element equine-specific cDNA microarray as previously described 3 . Median fluorescent intensities were adjusted for background and Lowess-normalized for each individual slide. Quantile regression was used as previously described 4 to estimate the conditional quantile of the M and A log ratios given the observed average log intensity. Briefly, a nonparametric approach was used to reveal the relationship between percentiles of M and A, where M is log 2 (R/G) and A is 0.5 log 2 (RG) with R representing expression in articular cartilage and G representing expression in the comparative tissue. The quantile regression was fit using a Bspline with five fixed nodes. The first, fifth, tenth, twentieth, fiftieth, eightieth, ninetieth, ninety-fifth, and ninety-ninth conditional quantiles were estimated. For each observed gene intensity in a given tissue comparison, the normal quantile was used as the cartilage-specificity in place of the corresponding estimated regression quantile. Microarray data are available at the NCBI Gene Expression Omnibus (GEO) 5, 6 under series accession number GSE23862. The microarray screen identified 37 genes with expression in articular cartilage above the 95th conditional quantile in all 10 of the cartilage/tissue comparisons analyzed (Z-scores ! 1.96 in all 10 comparisons). Of these, 13 (35%) had established annotation associated with chondrocytes or cartilage including well-established cartilage biomarkers such as hyaluronan and proteoglycan link protein 1 (HAPLN1), cartilage oligomeric matrix protein (COMP), aggrecan core protein (ACAN), procollagen type II alpha 1 (COL2A1), and procollagen type XI alpha 1 (COL11A1) 4 . The remaining 24 genes (65%) had no or very limited functional annotation that could be related directly to cartilage. One of these 24 genes was BOC (microarray cDNA probe corresponding to the EST in Genbank accession number CX600450.1). Across eight of the cartilage/tissue comparisons, BOC expression was in the upper 99th percentile of cartilage-specificity (Z-scores !2.57) and BOC expression remained in the 95th quantile for the other two tissues (Supplementary Table I ). CDO was not identified as having a cartilage-restricted pattern of expression at this same stringency threshold by the microarray screen. Previous published surveys of BOC and CDO expression in adult tissues had found low to undetectable levels, but neither of these sample sets included articular cartilage 1, 7 . To confirm the microarray data and quantitate steady state BOC mRNA levels across tissues, a real-time RT-qPCR assay was performed with consideration of MIQE guidelines 8 . Briefly, 500 ng of total RNA were reverse-transcribed (RT) into cDNA using commercial reagents and oligo-dT primers (Promega Corp., Madison, WI, #A3500 . RNA-seq, conducted using articular cartilage from a different horse, quantified BOC expression at 5.8-fold higher than the 34-day fetus, a value highly concordant with the qPCR data. Differences of approximately 30e55-fold were observed for cerebellum, placenta, and testes, which is somewhat lower than the RT-qPCR ratios. This likely reflects direct quantification of tag density that extends the dynamic range of RNA-seq especially for samples with very low levels of expression 12 . CDO relative expression ratios for the same tissue comparisons using RNA-seq were 2.1, 7.4, 11.0, and 16.8, respectively (Supplementary Table IV) . Protein localization was evaluated by immunohistochemistry with two independent BOC-specific antibodies, one monoclonal (R&D Systems Inc., Minneapolis, MN, #MAB20361) and one polyclonal (Imgenex, San Diego, CA, #IMG-30652). Immunostaining was performed using automated (Leica Bond-maxÔ Fully Automated IHC and ISH System, Leica Microsystems Inc., Bannockburn, IL) and manual (AvidineBiotin Complex Immunohistochemistry Staining System, Santa Cruz Biotechnology, Santa Cruz, California, # sc-2023) protocols. Sections processed manually were treated with 3% hydrogen peroxide, blocked in 1.5% serum, and incubated with a primary antibody overnight at 4 C. Following staining, the sections were counterstained with Gill No.3 hematoxylin (Sigma, #HS316). Articular chondrocytes in both pellet cultures (Fig. 1B) and cartilage tissue (Fig. 1C) displayed positive staining for BOC that appeared to localize to cell membranes. Lymph node (Supplementary Fig. 1A ) and other non-cartilaginous tissues (liver and small intestine, data not shown) were negative, as were experimental controls that deleted either the primary or secondary antibodies ( Supplementary Fig. 1B and C) . A comparison of articular cartilage collected from newborn foals (0e10 days of age) to adult horses (4e5 years of age) demonstrated a 2.4-fold increase in steady state BOC mRNA with maturation (P ¼ 0.013, Supplementary Table V) . No age-dependent difference was observed for CDO (P ¼ 0.633). This experiment also enabled inter-animal variation in articular cartilage BOC and CDO expression to be assessed. For the seven foals and six adult horses, the pooled standard error of the difference for BOC was 0.09 and for CDO was 0.06. To determine how tightly linked BOC and CDO expression are to the differentiated phenotype of articular chondrocytes, articular cartilage samples (n ¼ 4 horses) were compared to primary chondrocyte cultures (n ¼ 6 horses) over 28 days and three passages. The Mixed Procedure for SAS was used to log transform data and evaluate significant differences in mRNA expression. Steady state BOC and CDO mRNA levels dropped significantly (P < 0.001) even by completion of the chondrocyte isolation protocol (day 0, passage 0), and remained substantially lower than articular cartilage throughout the duration of the monolayer culture period (Table I) . As expected, levels of mRNA transcripts encoding procollagen type II alpha 1 (COL2A1) and ACAN were significantly down regulated, while procollagen type I alpha 2 (COL1A2) mRNA increased in the same samples (data not shown).
In published reports, BOC expression in embryonic tissues has generated functional annotation associated with developmental cellular differentiation and axon guidance 1, 2, 13 . Results of the current experiments are the first to identify high BOC mRNA levels in mature articular chondrocytes, a nondividing and differentiated population of cells. The apparent tissue-restricted pattern of this expression raises interesting questions regarding the functional role(s) of BOC and CDO in articular cartilage. During embryonic development, BOC functions as a cell-surface receptor for important signaling pathways including Hedgehog and p38 a/b MAPK 13, 14 . Indeed, BOC has been shown to specifically bind all three Hedgehog ligands with high affinity 15 . When the results of the current study are viewed in the context of known functional roles of BOC and CDO, it seems plausible that BOC facilitates articular chondrocyte specificity for conserved signaling pathways and contributes to receptor complex formation.
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